Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2019.0449
Abstract: Importance Polypoidal choroidal vasculopathy (PCV) is a major cause of visual loss worldwide, particularly in Asia, and the appropriate understanding of the structures in PCV previously described as polypoidal lesions is important for understanding their… read more here.
Keywords: using swept; angiography; swept source; polypoidal lesions ... See more keywords
Aflibercept With vs Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2025.0250
Abstract: This study compares the functional and anatomical benefit of combination therapy using reduced-fluence photodynamic therapy plus intravitreal aflibercept injection vs intravitreal aflibercept injection monotherapy in participants with polypoidal choroidal vasculopathy. read more here.
Keywords: reduced fluence; therapy; polypoidal choroidal; choroidal vasculopathy ... See more keywords
Choroidal remodeling after photodynamic therapy for polypoidal choroidal vasculopathy
Sign Up to like & getrecommendations! Published in 2018 at "Lasers in Surgery and Medicine"
DOI: 10.1002/lsm.22998
Abstract: We read with interest the article by Chen et al. [1] describing choroidal remodeling in eyes with polypoidal choroidal vasculopathy (PCV) following treatment with verteporfin photodynamic therapy (PDT). Using spectraldomain optical coherence tomography (OCT), the… read more here.
Keywords: choroidal; treatment; pdt; choroidal remodeling ... See more keywords
One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Sign Up to like & getrecommendations! Published in 2020 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-020-00312-3
Abstract: To evaluate 1-year outcomes of intravitreal aflibercept (IVA) using a treat-and-extend (TAE) regimen for polypoidal choroidal vasculopathy (PCV) and identify the factors for patients whose treatment intervals could be extended. Fifty-one eyes of treatment-naïve PCV… read more here.
Keywords: year; intravitreal aflibercept; eyes weeks; treat extend ... See more keywords
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study
Sign Up to like & getrecommendations! Published in 2024 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-024-00888-0
Abstract: The EVEREST II study previously reported that intravitreally administered ranibizumab (IVR) combined with photodynamic therapy (PDT) achieved superior visual gain and polypoidal lesion closure compared to IVR alone in patients with polypoidal choroidal vasculopathy (PCV).… read more here.
Keywords: year; polypoidal choroidal; choroidal vasculopathy; everest study ... See more keywords
Polypoidal choroidal vasculopathy in a case of retinitis pigmentosa, successfully treated with intravitreal aflibercept
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2021.101123
Abstract: Purpose Polypoidal choroidal vasculopathy (PCV) is a subtype of age-related macular degeneration that is seen frequently in Asians. Nevertheless, it is rare for this condition to be combined with retinitis pigmentosa (RP). The purpose of… read more here.
Keywords: retinitis pigmentosa; intravitreal aflibercept; right eye; polypoidal choroidal ... See more keywords
Infographic: “Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)”
Sign Up to like & getrecommendations! Published in 2022 at "Eye"
DOI: 10.1038/s41433-021-01874-7
Abstract: 1. Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET Study: a randomized clinical trial. JAMA Ophthalmol.… read more here.
Keywords: intravitreal aflibercept; polypoidal choroidal; trial; choroidal vasculopathy ... See more keywords
Association of imaging factors derived from convolutional neural network with visual outcomes in age-related macular degeneration and polypoidal choroidal vasculopathy
Sign Up to like & getrecommendations! Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-56420-z
Abstract: We investigated the association of visual outcome in typical neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) with or without pachychoroid with lesion areas on optical coherence tomography (OCT) quantified by convolutional neural… read more here.
Keywords: namd; macular degeneration; age related; related macular ... See more keywords
Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-00904-4
Abstract: This retrospective study aimed to evaluate the factors affecting recurrence and visual prognosis in patients with treatment-naïve subfoveal polypoidal choroidal vasculopathy (PCV). Patients who had received three consecutive intravitreal injections of ranibizumab or aflibercept and… read more here.
Keywords: choroidal; recurrence; group; recurrence visual ... See more keywords
PREVALENCE AND CLINICAL CHARACTERISTICS OF PACHYDRUSEN IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Multimodal Image Study
Sign Up to like & getrecommendations! Published in 2019 at "Retina"
DOI: 10.1097/iae.0000000000002019
Abstract: Purpose: To investigate the prevalence of a newly defined drusen type, pachydrusen, soft drusen, and subretinal drusenoid deposits in eyes with polypoidal choroidal vasculopathy and fellow eyes and the relationship between each drusen type and… read more here.
Keywords: polypoidal choroidal; choroidal vasculopathy; choroidal; prevalence ... See more keywords
POSTTREATMENT POLYP REGRESSION AND RISK OF MASSIVE SUBMACULAR HEMORRHAGE IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
Sign Up to like & getrecommendations! Published in 2018 at "Retina"
DOI: 10.1097/iae.0000000000002384
Abstract: PURPOSE To study the association between the risk of massive submacular hemorrhage (SMH) and polyp regression after initial treatment of polypoidal choroidal vasculopathy using long-term follow-up data. METHODS Retrospective study of 223 patients who were… read more here.
Keywords: massive smh; regression; risk massive; polypoidal choroidal ... See more keywords